Are DIY gene-testing kits a good idea?
By Sharon Brennan,
The Guardian
| 06. 13. 2016
“‘It’s like being told you’re going to be involved in a car crash, but you don’t know when it will hit. You know it is going to happen but you can’t do anything about it,” says Amy Burton. The 24-year-old from Kent was diagnosed with pre-type 1 diabetes in 2014 after she tested positive for auto-immune antibodies associated with the condition in a medical trial.
Burton had initially signed up as her younger sister has lived with type 1 diabetes for the past six years and she thought the experience would make an interesting blog post. She wasn’t expecting to find out that, within the next five to 15 years she, too, would have the condition: “I did sob when I heard,” she says.
Burton already knew how devastating type 1 diabetes can be, with complications such as blindness and amputations, while research also shows it can cut your life-expectancy by more than a decade. Now, she is constantly aware of her pre-diabetic status, has started exercising more and – although she has a healthy BMI – is conscious...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
